GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Odonate Inc (OTCPK:ODTCD) » Definitions » Earnings Yield (Joel Greenblatt) %
中文

Odonate (Odonate) Earnings Yield (Joel Greenblatt) %

: -416.67% (As of Sep. 2021)
View and export this data going back to 2017. Start your Free Trial

Odonate's Enterprise Value for the quarter that ended in Sep. 2021 was $-90.17 Mil. Odonate's EBIT for the trailing twelve months (TTM) ended in Sep. 2021 was $-91.90 Mil. Odonate's Earnings Yield (Joel Greenblatt) for the quarter that ended in Sep. 2021 was -416.67%.

The historical rank and industry rank for Odonate's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

ODTCD's Earnings Yield (Joel Greenblatt) % is not ranked *
in the Diversified Financial Services industry.
Industry Median: -1.68
* Ranked among companies with meaningful Earnings Yield (Joel Greenblatt) % only.

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Odonate's Forward Rate of Return (Yacktman) % for the quarter that ended in Sep. 2021 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Odonate Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for Odonate's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odonate Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Earnings Yield (Joel Greenblatt) %
Get a 7-Day Free Trial - -6.91 -38.17 -13.33 -21.65

Odonate Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -37.04 -21.65 -3,333.33 -400.00 -416.67

Competitive Comparison

For the Shell Companies subindustry, Odonate's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Odonate Earnings Yield (Joel Greenblatt) % Distribution

For the Diversified Financial Services industry and Financial Services sector, Odonate's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Odonate's Earnings Yield (Joel Greenblatt) % falls into.



Odonate Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Odonates Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2020 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-127.433/-151.864888
=83.91 %

Odonate's EBIT for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-91.90 Mil.



Odonate  (OTCPK:ODTCD) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


Odonate Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Odonate's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Odonate (Odonate) Business Description

Traded in Other Exchanges
N/A
Address
3 East 28th Street, 10th Floor, New York, NY, USA, 10016
Odonate Inc is a Shell company.
Executives
Ecor1 Capital, Llc 10 percent owner 357 TEHAMA STREET #3, SAN FRANCISCO CA 94103
Boxer Capital, Llc director, 10 percent owner 12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130
Kevin C Tang director, 10 percent owner, officer: Chief Executive Officer 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
Aaron I. Davis director, 10 percent owner 12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130
Craig A Johnson director C/O PURE BIOSCIENCE, 1725 GILLESPIE WAY, EL CAJON CA 92020
Jeff L Vacirca director 4747 EXECUTIVE DRIVE, SUITE 510, SAN DIEGO CA 92121
Laura L. Johnson director C/O LA JOLLA PHARMACEUTICAL COMPANY, LA JOLLA VILLAGE DRIVE, SUITE 1070, SAN DIEGO CA 92122
Michael S Hearne officer: Chief Financial Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Joseph P O'connell officer: Chief Medical Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Boxer Asset Management Inc. 10 percent owner CAY HOUSE, EP TAYLOR DRIVE N7776, LYFORD CAY, NEW PROVIDENCE C5 00000
Robert Rosen director C/O HERON THERAPEUTICS, INC, 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO CA 92121
Joseph Lewis 10 percent owner PO BOX N7776, LYFORD BAHAMAS
Tang Capital Management Llc 10 percent owner 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
Tang Capital Partners Lp 10 percent owner 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
John G Lemkey officer: Chief Financial Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121

Odonate (Odonate) Headlines

From GuruFocus

Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Sold $5.7 million of Shares

By GuruFocus Research GuruFocus Editor 11-20-2021

Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $4.2 million of Shares

By GuruFocus Research GuruFocus Editor 12-23-2020

Weekly CEO Buys Highlight

By Joy Hu Joy Hu 12-28-2020